research Diffuse hair loss in females
Stress, hypothyroidism, drug intake, and anemia are important factors in women's diffuse hair loss.
Search
for
Sort by
Research
300-330 / 1000+ results research Complementary Strategies to Promote Hair Regrowth in Post-COVID-19 Telogen Effluvium
Effective hair regrowth after COVID-19 involves psychological support, good nutrition, and hair growth treatments.
research Hemoglobin, ferritin and thyroid profile in women with chronic telogen effluvium
Low iron, low thyroid function, and stress are linked to excessive hair shedding in women.
research Telogen effluvium as a sign of Hodgkin disease
Hair loss might be an early sign of Hodgkin disease.
research Hirsutism, postpartum telogen effluvium, and male pattern alopecia
Hormonal changes during and after pregnancy can cause hair growth changes and hair loss, with treatments available for some conditions.
research Peculiar hypertrichosis in a patient affected by frontal fibrosing alopecia with pseudo "fringe sign"
A woman with frontal fibrosing alopecia experienced unusual hair growth after using a specific topical lotion.
research Telogen defluxion associated with hypersensitivity causing alopecia in a horse
A horse's sudden hair loss was caused by an allergic reaction to a coat conditioning powder.
research Interest of a vitamin and mineral supplement in the management of telogen effluvium: Clinical study on Brazilian women
A vitamin and mineral supplement significantly reduced hair shedding in Brazilian women with telogen effluvium.
research Serum Levels of Ferritin, Vitamin B12 and Folate in Patient with Telogen Effluvium Outside of the Menopause in Women
Low levels of ferritin and vitamin B12 are common in women with telogen effluvium, but the link between nutrient deficiencies and the condition is not clear.
research Temporal triangular alopecia
A 23-year-old man has a benign, non-progressive hair loss patch that doesn't respond to treatment but can be cosmetically treated.
research Greater susceptibility to telogen effluvium in the setting of severe COVID-19 infection: findings from a retrospective cohort study
Severe COVID-19 increases the risk of hair loss.
research NonScarring Diffuse Hair Loss in Women: a Clinico‐Etiological Study from tertiary care center in North‐West India
Most women in the study lost hair due to chronic shedding, with stress and nutrient deficiencies being common factors.
research The role of anemia and vitamin D levels in acute and chronic telogen effluvium
Low iron levels are a significant risk factor for hair loss, while high vitamin D levels might be a response to hair loss, not a cause.
research Culprits of Medication-Induced Telogen Effluvium, Part 2
Some blood thinners and blood pressure medicines can cause hair loss, which usually starts 1 to 6 months after beginning the medication.
research Questions and answers for clinical insights
Most hair loss in kids and teens is due to common conditions, and hair usually grows back within 6 months.
research Complementary Strategies to Promote Hair Regrowth in Post-COVID-19 Telogen Effluvium
Different methods, including stress management, healthy diet, supplements, and treatments like minoxidil, can help hair grow back after COVID-19 related hair loss.
research Postmenopausal frontal fibrosing alopecia
Postmenopausal frontal fibrosing alopecia is a type of hair loss in postmenopausal women that may stop on its own but has no effective treatment.
research Estimation of Serum Ferritin Level in Female Patients with Telogen
Serum ferritin levels do not cause hair loss in women with telogen effluvium.
research No todo es efluvio telógeno. Alopecia areata difusa una entidad infradiagnosticada
Accurate diagnosis of hair loss types is crucial for effective treatment.
research A pathophysiological and clinical review of androgenetic , areata, anagen effluvium, telogen effluvium and traction alopecia’s
Understanding different types of hair loss helps in accurate diagnosis and treatment.
research Efluvio telógeno y Covid-19
COVID-19 may cause hair loss due to the virus's effects and stress from the pandemic.
research The role of autologous micrografts injection from the scalp tissue in the treatment of COVID‐19 associated telogen effluvium: Clinical and trichoscopic evaluation
Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.
research Influência da suplementação nutricional no tratamento do eflúvio telógeno: avaliação clínica e por fototricograma digital em 60 pacientes
Nutritional supplements can significantly reduce hair loss in telogen effluvium after three months.
research Nonscarring scalp alopecia: Which laboratory analysis should we perform on whom?
Women with telogen effluvium should be tested first for vitamin and mineral deficiencies.
research Corrigendum: Analysis of Microscopic Examination of Pulled Out Hair in Telogen Effluvium Patients
The document corrects details about examining hair from patients with a hair loss condition called Telogen Effluvium.
research Biotin Deficiency in Telogen Effluvium: Fact or Fiction?
Biotin deficiency is not a major cause of Telogen Effluvium hair loss.
research Non-invasive method distinguishes chronic telogen effluvium from mild female pattern hair loss: clinicopathological correlation
Washing test helps identify hair loss type, low iron levels significant.
research Hair Loss in a Female Distance Runner
A female runner's hair loss was caused by stress from surgery and recovery, but her hair returned to normal in 5 months.
research Assessment of heavy metal levels in patients with Telogen effluvium- A clinical study
Patients with Telogen effluvium have higher levels of heavy metals than healthy individuals.
research Telogen Effluvium after SARS-CoV-2 Infection: A Series of Cases and Possible Pathogenetic Mechanisms
COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.